SVANasdaqPharmaceutical PreparationsFiscal year ends December 31

SINOVAC BIOTECH LTD

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Jun 5, 2026

$6.47+0.00 (0.00%)

Close on Oct 19, 2026

Community

Notes and questions about Sinovac Biotech from other investors

Discussion opens with sign-in. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.

Parsed from the XBRL in Sinovac Biotech's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is SVA.

Revenue growth6.8% · median 13.2%

Gross margin67.9% · median 56.5%

Operating margin-127.0% · median 7.4%

Advertisement
300 × 250